Pharma group is ‘stronger and leaner’ following administration

Two research scientists looking at microscope slides

Pharma group is ‘stronger and leaner’ following administration

Cancer and fibrosis drugs developer Redx Pharma says it is a stronger and leaner company having emerged from administration.

Announcing its results for the year to September 30, today, the Alderley Park-based business said this had been a “seminal year” during which it had been “transformed”.

It declared: “Since successfully exiting administration in November 2017, the restructured board and new management team is delivering on the refocused vision of discovering and developing novel drugs with the potential to transform the treatment of cancer and fibrosis.”

Read the article in full at

Important information

This information is of a general nature and does not constitute an offer to provide services.

The opinions and conclusions given here are those of Seneca Partners and are subject to change without notice.

The value of investments and/or any income arising from them may fluctuate.

Past performance is not necessarily a guide to future performance.

Important notice

The products and services shown on this website place capital at risk. Investors may receive less in returns than they have invested. Investments may not allow for capital to be withdrawn on demand. If an investment provides tax relief then this relief is subject to change and is dependant on personal circumstances. Any reference to past performance or forecasted performance is not a reliable indicator of future performance.

Seneca Partners recommends that any investor seeks specialised financial and/or tax advice before investing. Seneca Partners does not provide advice and the information on this website, including but not limited to news, should not be construed as such.

Please confirm that you understand this warning and wish to proceed.